Bilateral Panuveitis with Occlusive Vasculitis following Coronavirus Disease 2019 Vaccination

References

• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577.
   PubMed Web of Science ®Google Scholar
• Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–416. doi:10.1056/NEJMoa2035389.
   PubMed Web of Science ®Google Scholar
• Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111. doi:10.1016/S0140-6736(20)32661-1.
   PubMed Web of Science ®Google Scholar
• Abousy M, Bohm K, Prescott C, Bonsack JM, Rowhani-Farid A, Eghrari AO. Bilateral EK rejection after COVID-19 vaccine. Eye Contact Lens. 2021;47(11):625–628. doi:10.1097/ICL.0000000000000840.
   PubMed Web of Science ®Google Scholar
• Goyal M, Murthy SI, Annum S. Bilateral multifocal choroiditis following COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29(4):753–757. doi:10.1080/09273948.2021.1957123.
   PubMed Web of Science ®Google Scholar
• Mambretti M, Huemer J, Torregrossa G, Ullrich M, Findl O, Casalino G. Acute macular neuroretinopathy following coronavirus disease 2019 vaccination. Ocul Immunol Inflamm. 2021;29(4):730–733. doi:10.1080/09273948.2021.1946567.
   PubMed Web of Science ®Google Scholar
• Ng XL, Betzler BK, Testi I, et al. Ocular adverse events after COVID-19 vaccination. Ocul Immunol Inflamm. 2021:1–9. doi:10.1080/09273948.2021.1976221.
   PubMedGoogle Scholar
• Mudie LI, Zick JD, Dacey MS, Palestine AG. Panuveitis following vaccination for COVID-19. Ocul Immunol Inflamm. 2021;29(4):741–742. doi:10.1080/09273948.2021.1949478.
   PubMed Web of Science ®Google Scholar
• Bostan E, Gulseren D, and Gokoz O. New‐onset leukocytoclastic vasculitis after COVID‐19 vaccine. Int J Dermatol. 2021;60(10): 1305–1306. doi:10.1111/ijd.15777.
   PubMed Web of Science ®Google Scholar
• McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46–55. doi:10.1016/j.jaad.2021.03.092.
   PubMed Web of Science ®Google Scholar
• Kar BR, Singh BS, Mohapatra L, Agrawal I. Cutaneous small-vessel vasculitis following COVID-19 vaccine. J Cosmet Dermatol. 2021;20(11):3382–3383. doi:10.1111/jocd.14452.
   PubMed Web of Science ®Google Scholar
• Dash S, Behera B, Sethy M, Mishra J, Garg S. COVID‐19 vaccine‐induced urticarial vasculitis. Dermatol Ther. 2021;34:e15093. doi:10.1111/dth.15093.
   PubMed Web of Science ®Google Scholar
• Cohen SR, Prussick L, Kahn JS, Gao DX, Radfar A, and Rosmarin D. Leukocytoclastic vasculitis flare following the COVID‐19 vaccine. Int J Dermatol. 60(8):1032–1033. doi:10.1111/ijd.15623.
   PubMedGoogle Scholar
• Gillion V, Jadoul M, Demoulin N, Aydin S, Devresse A. Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine. Kidney Int. 2021;100(3):706–707. doi:10.1016/j.kint.2021.06.033.
   PubMed Web of Science ®Google Scholar
• Shakoor MT, Birkenbach MP, Lynch M. ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine. Am J Kidney Dis. 2021;78(4):611–613. doi:10.1053/j.ajkd.2021.06.016.
   PubMed Web of Science ®Google Scholar
• Ku JH, Ali A, Suhler EB, Choi D, Rosenbaum JT. Characteristics and visual outcome of patients with retinal vasculitis. Arch Ophthalmol. 2012;130(10):1261–1266. doi:10.1001/archophthalmol.2012.1596.
   PubMedGoogle Scholar
• Holder J. Tracking coronavirus vaccinations around the world. The New York Times. https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html. Published January 29, 2021. Accessed November 18, 2021.
   Google Scholar
• Éric T, Matthieu B. Vaccination and induction of autoimmune diseases. Inflammation Allergy - Drug Targets (Discontinued). 2015;14(2):94–98.
   PubMedGoogle Scholar
• Guimarães LE, Baker B, Perricone C, Shoenfeld Y. Vaccines, adjuvants and autoimmunity. Pharmacol Res. 2015;100:190–209. doi:10.1016/j.phrs.2015.08.003.
   PubMed Web of Science ®Google Scholar
• Kwok T, Al-Bermani A. Two rare cases of retinal vasculitis following vaccination. Scott Med J. 2013;58(2):e10–e12. doi:10.1177/0036933013482660.
   PubMed Web of Science ®Google Scholar
• Williams GS, Evans S, Yeo D, Al-bermani A. Retinal artery vasculitis secondary to administration of influenza vaccine. BMJ Case Rep. 2015;2015:bcr2015211971. doi:10.1136/bcr-2015-211971.
   PubMedGoogle Scholar
• Bonetto C, Trotta F, Felicetti P, et al. Vasculitis as an adverse event following immunization – systematic literature review. Vaccine. 2016;34(51):6641–6651. doi:10.1016/j.vaccine.2015.09.026.
   PubMed Web of Science ®Google Scholar
• Watanabe T. Vasculitis following influenza vaccination: a review of the literature. CRR. 2017;13:3. doi:10.2174/1573397113666170517155443.
   Google Scholar
• Commissioner O of the. Comirnaty and Pfizer-BioNTech COVID-19 vaccine. FDA. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/comirnaty-and-pfizer-biontech-covid-19-vaccine. Published online November 17, 2021. Accessed November 18, 2021.
   Google Scholar
• Quintana‐Castanedo L, Feito‐Rodríguez M, and Fernández‐Alcalde C, et al. Concurrent chilblains and retinal vasculitis in a child with COVID‐19. J Eur Acad Dermatol Venereol. 2020;34(12):e764–e766. doi:10.1111/jdv.16801.
   PubMed Web of Science ®Google Scholar
• Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020;50:499–511. doi:10.1007/s11239-020-02230-4.
   PubMed Web of Science ®Google Scholar
• Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020;217:108480. doi:10.1016/j.clim.2020.108480.
   PubMed Web of Science ®Google Scholar
• Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol. 2009;5(11):648–652. doi:10.1038/nrrheum.2009.196.
   PubMed Web of Science ®Google Scholar
• Segal Y, Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell Mol Immunol. 2018;15(6):586–594. doi:10.1038/cmi.2017.151.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Herbort CP, Tabbara KF. Retinal Vasculitis. Ocul Immunol Inflamm. 2005;13(6):415–433. doi:10.1080/09273940591003828.
   PubMed Web of Science ®Google Scholar
• Rosenbaum JT, Ku J, Ali A, Choi D, Suhler EB. Patients with retinal vasculitis rarely suffer from systemic vasculitis. Semin Arthritis Rheum. 2012;41(6):859–865. doi:10.1016/j.semarthrit.2011.10.006.
   PubMed Web of Science ®Google Scholar